ALS Drug Development Summit
Evvnt Promotion / evvnt
Archiv
24.05.2022 - 26.05.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 16:30
Kongressthemen
Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug development in ALS is exploding. With exciting new targets, revised inclusion criteria, and opportunities to implement digital biomarkers for remote and sensitive monitoring, we have never been closer to bringing meaningful therapies to patients.
Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug development in ALS is exploding. With exciting new targets, revised inclusion criteria, and opportunities to implement digital biomarkers for remote and sensitive monitoring, we have never been closer to bringing meaningful therapies to patients.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Amir Lahav, Head of Digital R and D, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma Holdings America, Andrew Wolff, Senior Vice President, Senior Fellow, Clinical Research and Development, Cytokinetics and more.
Speakers: Amir Lahav, Head of Digital R and D, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma Holdings America, Andrew Wolff, Senior Vice President, Senior Fellow, Clinical Research and Development, Cytokinetics and more.
Anfragen und Anmeldung:
https://go.evvnt.com/1004834-2?pid=4832
Frau Stephanie Nketia
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
